The "Sea" of Cancer

Co-Moderator(s)

• 

  Donna Rivera, PharmD, MSc, FISPE

  Associate Director of Pharmacoepidemiology
  Oncology Center of Excellence, US Food and Drug Administration
  Silver Spring, United States
• 

  Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his)

  Executive Director, Head of Epidemiology and Risk Management Operation
  BeiGene USA, Inc.
  Wyncote, United States

Presentations:

• 1:00 PM – 1:15 PM ADT

  Trajectories of Antidepressant Adherence Before Tamoxifen Initiation Among US Women with Breast Cancer
  

  Presenting Author: Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research
• 1:15 PM – 1:30 PM ADT

  The Association Between Pre-Existing Type 2 Diabetes on Breast Cancer-Related and Overall Mortality Among Women with Breast Cancer
  

  Presenting Author: Kristina Parsons, RD – McGill University
• 1:30 PM – 1:45 PM ADT

  Risk of Childhood Leukemia and Lymphoma after In-utero Exposure to Maternal Diabetes and Antidiabetics – a Nordic Population-based Study
  

  Presenting Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
• 1:45 PM – 2:00 PM ADT

  Incidence of Second Primary Malignancies (SPMs) in Patients in the US with Triple-Class-Exposed (TCE) Relapsed or Refractory Multiple Myeloma (RRMM)
  

  Presenting Author: Wenzhen Ge, PhD (she/her/hers) – Regeneron Pharmaceuticals
• 2:00 PM – 2:15 PM ADT

  Maintenance proton pump inhibitor usage and risk of colorectal cancer: A population-based Swedish cohort study
  

  Presenting Author: Qing Liu, MD – Karolinska Institutet
• 2:15 PM – 2:30 PM ADT

  Multiple models to evaluate the prognostic factors of disease progression after R0 esophagectomy for Chinese patients with squamous cell carcinoma
  

  Presenting Author: Qingqing Hu, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, China